Dianthus Therapeutics, Inc. (DNTH) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$76.07
Day's range
$84.86

Dianthus Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 7.77 M $651.86 M   20.78% 20.55%
BLACKROCK, INC. 05/13/2026 3.18 M $266.50 M   65.81% 8.40%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 2.61 M $219.18 M   62.05% 6.91%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.60 M $217.84 M   3.70% 6.87%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 2.54 M $212.92 M   18.72% 6.71%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 2.10 M $176.58 M   0.00% 5.57%
05/15/2026 2.03 M $170.46 M   100.00% 5.37%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 1.95 M $163.36 M   -19.45% 5.15%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 1.68 M $140.70 M   0.00% 4.44%
CITADEL ADVISORS LLC 05/15/2026 1.61 M $135.15 M   50.66% 4.26%
STATE STREET CORP 05/15/2026 1.40 M $117.40 M   -7.21% 3.70%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 1.29 M $108.44 M   100.00% 3.42%
VR ADVISER, LLC 05/15/2026 1.18 M $99.03 M   18.00% 3.12%
FRED ALGER MANAGEMENT, LLC 05/15/2026 1.16 M $97.51 M   3,372.57% 3.07%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.15 M $96.25 M   86.18% 3.03%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.08 M $90.30 M   7.09% 2.85%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 1.02 M $85.58 M   100.00% 2.70%
FRANKLIN RESOURCES INC 05/13/2026 968.18 K $81.25 M   109.19% 2.56%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 950.00 K $79.72 M   100.00% 2.51%
ALLIANCEBERNSTEIN L.P. 05/15/2026 926.07 K $38.16 M   10.99% 2.45%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 916.21 K $76.90 M   35.40% 2.42%
BRAIDWELL LP 05/15/2026 899.36 K $75.47 M   -29.40% 2.38%
BAKER BROS. ADVISORS LP 05/15/2026 852.16 K $71.51 M   7.90% 2.25%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 836.00 K $70.16 M   100.00% 2.21%
UBS GROUP AG 05/05/2026 781.28 K $65.57 M   28.79% 2.07%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 654.75 K $54.95 M   -12.72% 1.73%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 643.60 K $54.01 M   -44.81% 1.70%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 560.31 K $47.02 M   -14.27% 1.48%
GOLDMAN SACHS GROUP INC 05/15/2026 548.01 K $45.99 M   -5.03% 1.45%
JENNISON ASSOCIATES LLC 05/06/2026 485.14 K $40.71 M   100.00% 1.28%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 474.09 K $39.79 M   100.00% 1.25%
WOODLINE PARTNERS LP 05/15/2026 433.46 K $36.38 M   103.42% 1.15%
SAMLYN CAPITAL, LLC 05/15/2026 431.12 K $36.18 M   100.00% 1.14%
BIOIMPACT CAPITAL LLC 05/15/2026 423.98 K $35.58 M   100.00% 1.12%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 400.00 K $33.57 M   26.98% 1.06%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/13/2026 382.12 K $32.07 M   100.00% 1.01%
BARCLAYS PLC 05/15/2026 379.61 K $31.86 M   115.32% 1.00%
05/14/2026 373.27 K $31.33 M   25.50% 0.99%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 370.05 K $31.05 M   -22.01% 0.98%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2026 362.47 K $30.42 M   -51.25% 0.96%
AMERIPRISE FINANCIAL INC 05/15/2026 358.47 K $30.08 M   131.03% 0.95%
VIVO CAPITAL, LLC 05/20/2026 354.00 K $29.71 M   0.00% 0.94%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 350.00 K $29.37 M   204.35% 0.93%
05/08/2026 349.38 K $29.32 M   100.00% 0.92%
MARSHALL WACE, LLP 05/15/2026 341.93 K $28.69 M   -66.10% 0.90%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 325.44 K $27.30 M   54.48% 0.86%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 317.31 K $26.63 M   100.00% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 305.44 K $25.63 M   21.78% 0.81%
NORTHERN TRUST CORP 05/14/2026 303.75 K $25.49 M   46.57% 0.80%
LORD, ABBETT & CO. LLC 05/14/2026 299.21 K $25.11 M   100.00% 0.79%

Dianthus Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 263 institutional investors and hedge funds held shares of Dianthus Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 7.77 M

BlackRock, Inc.: 3.18 M

RA CAPITAL MANAGEMENT, L.P.: 2.61 M

WELLINGTON MANAGEMENT GROUP LLP: 2.6 M

Fairmount Funds Management LLC: 2.54 M

Avidity Partners Management LP: 2.1 M

164.38% of Dianthus Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 63.30 M shares in the last 24 months. This purchase volume represents approximately $5.02 B in transactions.